Suppr超能文献

预防性网片覆盖加强与单纯缝合预防中线切口疝的随机对照多中心双盲 2 年随访研究(PRIMA)

Prevention of incisional hernia with prophylactic onlay and sublay mesh reinforcement versus primary suture only in midline laparotomies (PRIMA): 2-year follow-up of a multicentre, double-blind, randomised controlled trial.

机构信息

Department of Surgery, Erasmus University Medical Centre, Rotterdam, Netherlands.

Department of Surgery, Erasmus University Medical Centre, Rotterdam, Netherlands; Department of Surgery, Maasstad Ziekenhuis, Rotterdam, Netherlands.

出版信息

Lancet. 2017 Aug 5;390(10094):567-576. doi: 10.1016/S0140-6736(17)31332-6. Epub 2017 Jun 20.

Abstract

BACKGROUND

Incisional hernia is a frequent long-term complication after abdominal surgery, with a prevalence greater than 30% in high-risk groups. The aim of the PRIMA trial was to evaluate the effectiveness of mesh reinforcement in high-risk patients, to prevent incisional hernia.

METHODS

We did a multicentre, double-blind, randomised controlled trial at 11 hospitals in Austria, Germany, and the Netherlands. We included patients aged 18 years or older who were undergoing elective midline laparotomy and had either an abdominal aortic aneurysm or a body-mass index (BMI) of 27 kg/m or higher. We randomly assigned participants using a computer-generated randomisation sequence to one of three treatment groups: primary suture; onlay mesh reinforcement; or sublay mesh reinforcement. The primary endpoint was incidence of incisional hernia during 2 years of follow-up, analysed by intention to treat. Adjusted odds ratios (ORs) were estimated by logistic regression. This trial is registered at ClinicalTrials.gov, number NCT00761475.

FINDINGS

Between March, 2009, and December, 2012, 498 patients were enrolled to the study, of whom 18 were excluded before randomisation. Therefore, we included 480 patients in the primary analysis: 107 were assigned primary suture only, 188 were allocated onlay mesh reinforcement, and 185 were assigned sublay mesh reinforcement. 92 patients were identified with an incisional hernia, 33 (30%) who were allocated primary suture only, 25 (13%) who were assigned onlay mesh reinforcement, and 34 (18%) who were assigned sublay mesh reinforcement (onlay mesh reinforcement vs primary suture, OR 0·37, 95% CI 0·20-0·69; p=0·0016; sublay mesh reinforcement vs primary suture, 0·55, 0·30-1·00; p=0·05). Seromas were more frequent in patients allocated onlay mesh reinforcement (34 of 188) than in those assigned primary suture (five of 107; p=0·002) or sublay mesh reinforcement (13 of 185; p=0·002). The incidence of wound infection did not differ between treatment groups (14 of 107 primary suture; 25 of 188 onlay mesh reinforcement; and 19 of 185 sublay mesh reinforcement).

INTERPRETATION

A significant reduction in incidence of incisional hernia was achieved with onlay mesh reinforcement compared with sublay mesh reinforcement and primary suture only. Onlay mesh reinforcement has the potential to become the standard treatment for high-risk patients undergoing midline laparotomy.

FUNDING

Baxter; B Braun Surgical SA.

摘要

背景

切口疝是腹部手术后常见的长期并发症,在高危人群中的发生率大于 30%。PRIMA 试验的目的是评估在高危患者中使用网片加强预防切口疝的效果。

方法

我们在奥地利、德国和荷兰的 11 家医院进行了一项多中心、双盲、随机对照试验。我们纳入了年龄在 18 岁或以上、接受择期中线剖腹术且患有腹主动脉瘤或体质量指数(BMI)≥27kg/m²的患者。我们使用计算机生成的随机序列将参与者随机分配至以下三组治疗之一:一期缝合;网片覆盖加强;或网片下置加强。主要终点是 2 年随访期间的切口疝发生率,采用意向治疗进行分析。通过逻辑回归估计调整后的比值比(OR)。该试验在 ClinicalTrials.gov 注册,编号为 NCT00761475。

结果

2009 年 3 月至 2012 年 12 月期间,共纳入 498 名患者参与该研究,其中 18 名患者在随机分组前被排除在外。因此,我们将 480 名患者纳入主要分析:107 名仅接受一期缝合,188 名接受网片覆盖加强,185 名接受网片下置加强。92 名患者被确诊为切口疝,其中 33 名(30%)仅接受一期缝合,25 名(13%)接受网片覆盖加强,34 名(18%)接受网片下置加强(网片覆盖加强与一期缝合相比,OR 0.37,95%CI 0.20-0.69;p=0.0016;网片下置加强与一期缝合相比,0.55,0.30-1.00;p=0.05)。与接受一期缝合(5 例)或网片下置加强(13 例)的患者相比,接受网片覆盖加强的患者更常发生血清肿(188 例中 34 例)(p=0.002)。各组间的伤口感染发生率无差异(一期缝合 14 例;网片覆盖加强 25 例;网片下置加强 19 例)。

结论

与网片下置加强和仅一期缝合相比,网片覆盖加强显著降低了切口疝的发生率。网片覆盖加强有可能成为高危人群行中线剖腹术的标准治疗方法。

资助

Baxter;B Braun Surgical SA。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验